Visioneering Technologies, Inc. (VTI.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - AUD | -100.0% |
| 2022 | 1.2 Million USD | -55.89% |
| 2021 | 2.74 Million AUD | -3.14% |
| 2020 | 2.83 Million AUD | -1.15% |
| 2019 | 2.86 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | -100.0% |
| 2016 | 13.46 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q4 | 193.67 Thousand USD | -5.68% |
| 2023 Q2 | 115.6 Thousand USD | 0.37% |
| 2023 FY | - AUD | -100.0% |
| 2023 Q1 | 115.17 Thousand USD | -90.47% |
| 2023 Q3 | 205.33 Thousand USD | 77.62% |
| 2022 Q2 | 3.99 Million USD | 8.39% |
| 2022 Q4 | 1.2 Million USD | -45.62% |
| 2022 FY | 1.2 Million USD | -55.89% |
| 2022 Q1 | 3.68 Million USD | 34.51% |
| 2022 Q3 | 2.22 Million USD | -44.36% |
| 2021 Q1 | 3.75 Million USD | 2.22% |
| 2021 FY | 2.74 Million AUD | -3.14% |
| 2021 Q4 | 2.74 Million AUD | -27.97% |
| 2021 Q3 | 3.8 Million USD | 0.02% |
| 2021 Q2 | 3.8 Million USD | 1.3% |
| 2020 Q4 | 3.67 Million AUD | -33.87% |
| 2020 FY | 2.83 Million AUD | -1.15% |
| 2020 Q1 | 6.62 Million USD | 131.5% |
| 2020 Q2 | 5.9 Million USD | -10.89% |
| 2020 Q3 | 5.55 Million USD | -5.92% |
| 2019 Q4 | 2.86 Million AUD | -32.51% |
| 2019 FY | 2.86 Million AUD | 0.0% |
| 2019 Q3 | 4.24 Million USD | 1077.06% |
| 2019 Q2 | 360.37 Thousand USD | 1.14% |
| 2019 Q1 | 356.32 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | - AUD | -100.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 FY | 13.46 Million AUD | 0.0% |
| 2016 Q4 | 13.51 Million USD | 6.07% |
| 2016 Q3 | 12.74 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 100.0% |
| Adherium Limited | - AUD | NaN% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 100.0% |
| Atomo Diagnostics Limited | - AUD | NaN% |
| Anteris Technologies Ltd | 1.52 Million AUD | 100.0% |
| Control Bionics Limited | 336.16 Thousand AUD | 100.0% |
| CardieX Limited | - AUD | NaN% |
| Compumedics Limited | - AUD | NaN% |
| Cochlear Limited | 202.1 Million AUD | 100.0% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 100.0% |
| Cyclopharm Limited | 4.01 Million AUD | 100.0% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 100.0% |
| Nova Eye Medical Limited | - AUD | NaN% |
| HeraMED Limited | - AUD | NaN% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 100.0% |
| ImpediMed Limited | 810 Thousand AUD | 100.0% |
| InhaleRx Limited | - AUD | NaN% |
| LBT Innovations Limited | 1.74 Million AUD | 100.0% |
| Micro-X Limited | 65 Thousand AUD | 100.0% |
| Neurotech International Limited | - AUD | NaN% |
| OncoSil Medical Limited | - AUD | NaN% |
| PolyNovo Limited | 742 Thousand AUD | 100.0% |
| Respiri Limited | - AUD | NaN% |
| SomnoMed Limited | 709.07 Thousand AUD | 100.0% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 100.0% |
| Uscom Limited | - AUD | NaN% |